Диссертация (1145983), страница 33
Текст из файла (страница 33)
F.Watts // An International Journal of Medicine. - 2006. - Vol. 99, № 5. - P. 277-287.89. Chappell, S. Searching for genetic clues to the causes of pre-eclampsia / S. Chappell, L.Morgan // Clin Sci (Lond). - 2006. - Vol. 110, № 4. - P. 443-458.90. Chelbi, S. T.
Expressional and epigenetic alterations of placental serine protease inhibitors:SERPINA3 is a potential marker of preeclampsia / S. T. Chelbi, F. Mondon, H. Jammes [et al.]// Hypertension. - 2007. - Vol. 49, № 1. - P. 76-83.91. Chen, D. B. Human placental microRNAs and preeclampsia / D.
B. Chen, W. Wang // BiolReprod. - 2013. - Vol. 88, № 5: 130. - P. 1-11.92. Chenthuran, T. Polymorphism in the epidermal growth factor gene is associated with preeclampsia and low birthweight / T. Chenthuran, G. H. Galhenagey, R. W. Jayasekara, V. H.Dissanayake // J Obstet Gynaecol Res. - 2014. - Vol. 40, № 5. - P. 1235-1242.93. Chesley L. C. Genetics of hypertension in pregnancy: possible single gene control of preeclampsia and eclampsia in descendants of eclamptic women / L.
C. Chesley, D. W. Cooper //Br J Obstet Gynaecol. - 1986. - Vol. 93, № 9. - P. 898-908.94. Chesley, L. C. The familial factor in toxemia of pregnancy / L. C. Chesley, J. E. Annitto, R.A.Cosgrove // Obstet Gynecol. - 1968. -Vol. 32, № 3. - P. 303-311.95. Chim, S. S. Detection and characterization of placental microRNAs in maternal plasma / S. S.Chim, T. K. Shing, E. C. Hung [et al.] // Clin Chem. - 2008. - Vol. 54, № 3.
- P. 482-490.13696. Choi, S. Y. MicroRNA expression profiles in placenta with severe preeclampsia using a PNAbased microarray / S. Y. Choi, J. Yun, O. J. Lee [et al.] // Placenta. - 2013. - Vol. 34, № 9. - P.799-804.97. Choudhury, M. Epigenetics and microRNAs in preeclampsia / M. Choudhury, J. E. Friedman //Clin Exp Hypertens. - 2012. - Vol. 34, № 5. - P. 334-341.98. Cincotta, R. B. Family history of pre-eclampsia as a predictor for pre-eclampsia inprimigravidas / R.
B. Cincotta, S. P. Brennecke // Int J Gynaecol Obstet - 1998. - Vol. 60, № 1. P. 23-27.99. Clark, P. The GOAL study: a prospective examination of the impact of Factor V Leiden andABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes // P. Clark, I. D.Walker, L. Govan [et al.] // Br J Haematol. - 2008.
- Vol. 140, № 2. - P. 236-240.100. Cnattingius, S. Maternal and fetal genetic factors account for most of familial aggregation ofpreeclampsia / S. Cnattingius, M. Reilly, Y. Pawitan, P. Lichtenstein // Am J Med Genet. 2004. - Vol. 130A, № 4. - P.
365-371.101. Coolman, M. Matrix metalloproteinase-9 gene -1562CT polymorphism mitigates preeclampsia/ M. Coolman, M. de Maat, W. L. Van Heerde [et al.] // Placenta. - 2007. - Vol. 28, № 7. - P.709-713.102. Cooper, D. W. Genetic control of severe pre-eclampsia / D. W. Cooper, W. A. Liston // J MedGenet. - 1979. - Vol. 16, № 6. - P. 409-416.103.
Dahlman, I. Functional and genetic analysis in type 2 diabetes of liver X receptor alleles–acohort study / I. Dahlman, M. Nilsson, H. F. Gu [et al.] // BMC Med Genet. - 2009. - Vol. 7: 27.- 13 p.104. Dai, B. The polymorphism for endothelial nitric oxide synthase gene, the level of nitric oxideand the risk for pre-eclampsia: a meta-analysis / B. Dai, T. Liu, B. Zhang [et al.] // Gene.
- 2013.- Vol. 519, № 1. - P. 187-193.105. Dalmaz, C. A. Relationship between polymorphisms in thrombophilic genes and preeclampsiain a Brazilian population / C. A. Dalmaz, K. G. Santos, M. R. Botton [et al.] // Blood Cells MolDis. - 2006. - Vol. 37, № 2.
- P. 107-110.106. Dawson, S. J. The two allele sequences of a common polymorphism in the promoter of theplasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin–1 in HepG2cells / S. J. Dawson, B. Wiman, A. Hamsten // J. Biol. Chem. - 1993. - Vol. 268, № 15. - P.10739-10745.107. Dizon-Townson, D. The relationship of the factor V Leiden mutation and pregnancy outcomesfor mother and fetus / D.
Dizon-Townson, C. Miller, B. Sibai [et al.] // Obstet Gynecol. - 2005. Vol. 106, № 3. - P. 517-524.137108. Duckitt, K. Risk factors for pre-eclampsia at antenatal booking: systematic review ofcontrolled studies / K. Duckitt, D. Harrington // BMJ. - 2005. - Vol. 330, № 7491. - P. 565-567.109. Dudding, T.
Factor V Leiden is associated with pre-eclampsia but not with fetal growthrestriction: a genetic association study and meta-analysis / T. Dudding, J. Heron, A.Thakkinstian [et al.] // J Thromb Haemost. - 2008. - Vol. 6, № 11. - P. 1869-1875.110.Duley, L. Antiplatelet agents for preventing pre-eclampsia and its complications / L. Duley, D.J. Henderson-Smart, M. Knight, J. F. King // Cochrane Database Syst Rev. - 2004.
- Vol. 18, №2, Article № CD004659. - 20 p.111. Enquobahrie, D. A. Placental microRNA expression in pregnancies complicated bypreeclampsia / D. A. Enquobahrie, D. F. Abetew, T. K. Sorensen [et al.] // Am J ObstetGynecol. - 2011. - Vol. 204, № 2. - P. 178.e12-178.e21.112. Esplin, M. S. Paternal and maternal components of the predisposition to preeclampsia / M.
S.Esplin, M. B. Fausett, A. Fraser [et al.] // N Engl J Med. - 2001. - Vol. 344, № 12. - P. 867-872.113.Fabbro, D. Association between plasminogen activator inhibitor 1 gene polymorphisms andpreeclampsia / D. Fabbro, A. V. D'Elia, R. Spizzo [et al.] // Gynecol Obstet Invest. - 2003. Vol. 56, № 1. - P. 17-22.114. Faisel, F. Susceptibility to pre-eclampsia in Finnish women is associated with R485Kpolymorphism in the factor V gene, not with Leiden mutation / F.
Faisel, E. L. Romppanen, M.Hiltunen [et al.] // Eur J Hum Genet. 2004. - Vol. 12, № 3. - P. 187-191.115. Fatini, C. Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, therecurrence of negative pregnancy events, and the maternal-fetal flow / C. Fatini, E. Sticchi, F.Gensini [et al.] // J Hypertens. - 2006. - Vol. 24, № 9.
- P. 1823-1829.116. Fitzpatrick, E. Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia/ E. Fitzpatrick, M. P. Johnson, T. D. Dyer [et al.] // Mol Hum Reprod. - 2009. - Vol. 15, № 3. P. 195-204.117. Folgero, T. Mutations in mitochondrial transfer ribonucleic acid genes in preeclampsia / T.Folgero, N. Storbakk, T. Torbergsen, P. Oian // Am J Obstet Gynecol.
- 1996. - Vol. 174, № 5. P. 1626-1630.118. Friedlander, M. R. miRDeep2 accurately identifies known and hundreds of novel microRNAgenes in seven animal clades / M. R. Friedlander, S. D. Mackowiak, N. Li [et al.] // NucleicAcids Res. - 2012. - Vol. 40, № 1. - P. 37-52.119. Fu, G. MicroRNAs in human placental development and pregnancy complications / G. Fu, J.Brkić, H. Hayder, C. Peng // Int J Mol Sci. - 2013. - Vol. 14, № 3. - P. 5519-5544.138120. Furness, D. L.
One-carbon metabolism enzyme polymorphisms and uteroplacentalinsufficiency / D. L. Furness, M. F. Fenech, Y. T. Khong [et al.] // Am J Obstet Gynecol. 2008. - Vol. 199, № 3. - P. 276.e1-276.e8.121. Gerhardt, A. The G20210A prothrombin-gene mutation and the plasminogen activatorinhibitor (PAI-1) 5G5G genotype are associated with early onset of severe preeclampsia / A.Gerhardt, T. W.
Goecke, M. W. Beckmann [et al.] // J Thromb Haemost. - 2005a. - Vol. 3, № 4.- P. 686–691.122. Gerhardt, A. The polymorphism of platelet membrane integrin alpha2beta1 (alpha2807TT) isassociated with premature onset of fetal loss / A. Gerhardt, R. E. Scharf, B. Mikat-Drozdzynski[et al.] // Thromb Haemost. - 2005b. - Vol.
93, № 1. - P. 124-129.123.Ghulmiyyah, L. Maternal mortality from preeclampsia/eclampsia / L. Ghulmiyyah, B. Sibai //Semin Perinatol. - 2012. - Vol. 36, № 1. - P. 56–59.124. Gilad, S. Serum microRNAs are promising novel biomarkers / S. Gilad, E. Meiri, Y. Yogev [etal.] // PLoS One. - 2008. - Vol. 3, № 9: e3148. - 7 p.125. Girelli, D. Polymorphisms in the factor VII gene and the risk of myocardial infarction inpatients with coronary artery disease / D. Girelli, C. Russo, R.
Corrocher [et al.] // N Engl JMed. - 2000. - Vol. 343, № 11. - P. 774-780.126.Goddard, A. B. Candidate-Gene Association Study of Mothers with Pre Eclampsia, and TheirInfants, Analyzing 775 SNPs in 190 Genes / A. B. Goddard, G. Tromp, R.
Romero [et al.] //Hum. Hered. - 2007. - Vol. 63, № 1. - P. 1-16.127.Gojnic, M. Plasma albumin level as an indicator of severity of preeclampsia / M. Gojnic, S.Petkovic, M. Papic [et al.] // Clin Exp Obstet Gynecol. - 2004. - Vol. 31, № 3. - P. 209-210.128.Goodwin, A. A. Does maternal race or ethnicity affect the expression of severe preeclampsia? /A. A. Goodwin, Mercer B. M. // Am J Obstet. Gynecol. - 2005. - Vol.
193, № 3 Pt 2. - P. 973978.129.GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: aBritish multicenter candidate-gene study / GOPEC Consortium // Am J Hum Genet. - 2005. Vol. 77, № 1. - P. 127–131.130. Grandone, E. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility topreeclampsia / E. Grandone, M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
